Serial 85051903
Live / Registered — Registered and renewed (as of 16 Jan 2020)
What this means for you
Registered since 23 Nov 2010. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 23 Nov 2020).
Record
- Serial number
- 85051903
- Registration number
- 3880072
- Mark type
- Design / logo
- Filed
- 01 Jun 2010
- Published for opposition
- 07 Sept 2010
- Registered
- 23 Nov 2010
- Next maintenance due
- 23 Nov 2020
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of blood disease and cancer and printed dosage instructional manuals sold together as a unit
Owner
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
- Celgene Corporation, Summit, NJ, US
Prior registrations
Prosecution history
- 09 Dec 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 09 Dec 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 09 Dec 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 09 Dec 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 09 Dec 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 09 Dec 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 16 Jan 2020 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 16 Jan 2020 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 16 Jan 2020 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 15 Jan 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Nov 2019 — TEAS SECTION 8 & 9 RECEIVED
- 23 Nov 2019 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Feb 2016 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 02 Feb 2016 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 02 Feb 2016 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL